Global Parkinson's Disease Market Size, Status and Forecast 2019-2025

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
In 2018, the global Parkinson's Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Parkinson's Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson's Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia

Market segment by Type, the product can be split into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parkinson's Disease status, future forecast, growth opportunity, key market and key players.
To present the Parkinson's Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson's Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.